Location History:
- Worthington, OH (US) (2002 - 2019)
- Columbus, OH (US) (1993 - 2022)
Company Filing History:
17 out of 1,506 
1 out of 2,202 
Years Active: 1993-2022
Title: **Yasuko Rikihisa: Pioneering Innovations in Healthcare**
Introduction
Yasuko Rikihisa, based in Worthington, OH, is a noted inventor with a remarkable portfolio of 18 patents. Her work primarily focuses on advancements in treating infections caused by obligatory intracellular bacteria, significantly contributing to the field of immunology and infectious diseases.
Latest Patents
Among her latest patents, Yasuko has developed groundbreaking methods involving intracellular nanobodies that target the T4SS effector, specifically designed to inhibit Ehrlichia infection. This innovation reveals that the translocated factor-1 (Etf-1), which functions as a primary virulence factor, can be effectively blocked by these nanobodies. This comes as a crucial step in developing treatments for human monocytic ehrlichiosis (HME) by utilizing these novel antibodies.
Additionally, Yasuko's patents encompass vaccines containing immunogenic polypeptides derived from EtpE proteins. These include methods for diagnosing Ehrlichiosis through biological samples, signifying significant advancements in diagnostic and therapeutic strategies in the realm of intracellular bacterial infections.
Career Highlights
Yasuko Rikihisa has made significant contributions during her tenure at esteemed institutions such as The Ohio State University and the Ohio State Innovation Foundation. Her research has not merely been theoretical but has translated into practical applications that address significant health challenges.
Collaborations
Throughout her career, Yasuko has collaborated with notable peers, including Norio Ohashi and Dipu Mohan-Kumar. These partnerships have fostered an environment of innovation, driving forward the research that underpins her groundbreaking patents.
Conclusion
Yasuko Rikihisa stands as a prominent figure in the realm of healthcare innovations. Her extensive research and development of patents demonstrate a commitment to combating intracellular bacterial infections and advancing medical treatments. With her continual contributions, she not only leads the field forward but also inspires future generations of researchers and inventors.